Article
Nras in melanoma: targeting the undruggable target.
Critical reviews in oncology/hematology - 1 Nov 2014
Mandalà Mario, Merelli Barbara, Massi Daniela
Abstract excerpt
RAS belongs to the guanosine 5'-triphosphate (GTP)-binding proteins' family, and oncogenic mutations in codons 12, 13, or 61 of RAS family occur in approximately one third of all human cancers with N-RAS mutations found in about 15-20% of melanomas. The importance of RAS signaling as a potential target in cancer is emphasized not only by the prevalence of RAS mutations, but also by the high number of RAS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
